Enoxaparin Export Market Intelligence: India's 223 Suppliers Shipping to 118 Countries — TransData Nexus 2026

Q: Who are the top enoxaparin exporters from India?

The top enoxaparin exporters from India are: 1. GLAND PHARMA LIMITED — $79.0M (37.7% market share); 2. GLAND PHARMA LTD — $69.8M (33.3% market share); 3. BIOLOGICAL E. LIMITED — $23.7M (11.3% market share); 4. VENUS REMEDIES LIMITED — $5.1M (2.4% market share); 5. BRAWN LABORATORIES LIMITED — $4.1M (2.0% market share). Together they account for 86.8% of India's total enoxaparin export value.

Q: What is the total export value of enoxaparin from India?

The total export value of enoxaparin from India is $209.4M USD, recorded across 3,309 shipment transactions from 223 active exporters to 118 destination countries. The average shipment value is $63.3K.

Q: Which countries import enoxaparin from India?

India exports enoxaparin to 118 countries worldwide. The top importing countries are: UNITED STATES (49.0% share, $102.7M), SAUDI ARABIA (22.0% share, $46.1M), SRI LANKA (3.8% share, $7.9M), CANADA (2.5% share, $5.2M), DOMINICAN REPUBLIC (1.6% share, $3.4M). These five markets account for 78.9% of total export value.

Q: What is the HS code for enoxaparin exports from India?

The primary HS code for enoxaparin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of enoxaparin exports from India?

The average unit price for enoxaparin exports from India is $105.76 USD per unit, with prices ranging from $0.00 to $61483.79 depending on formulation, packaging, and order volume. The total market is valued at $209.4M across 3,309 shipments.

Q: Which ports handle enoxaparin exports from India?

The primary ports for enoxaparin exports from India are HYDERABAD ICD (16.8% of shipments), HYDERABAD ICD (INSNF6) (13.8% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.3% of shipments), SAHAR AIR (7.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (5.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of enoxaparin?

India is one of the world's leading exporters of enoxaparin due to its large base of 223 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports enoxaparin to 118 countries, demonstrating 61% global market coverage.

Q: What certifications do Indian enoxaparin exporters need?

Indian enoxaparin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import enoxaparin from India?

There are 505 registered buyers importing enoxaparin from India, spread across 118 countries. The repeat buyer rate is 71.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top enoxaparin supplier from India?

GLAND PHARMA LIMITED is the leading enoxaparin exporter from India with a market share of 37.7% and total export value of $79.0M across 495 shipments. The top 5 suppliers together control 86.8% of total export value.

Suresh Sormare

Enoxaparin

India Pharmaceutical Trade Intelligence

$209.4M223 Suppliers118 CountriesHS 30049099

ExportsIndia → UNITED STATES49.0%India → SAUDI ARABIA22.0%

ImportsFRANCE → India$2.7B CHINA → India$3.2M

#1 Supplier: GLAND PHARMA #1 Buyer: FRESENIUS KABI

Enoxaparin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Enoxaparin to the World

Between 2022 and 2026, India exported $209.4M worth of enoxaparin across 3,309 verified shipments to 118 countries — covering 61% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (49.0%). GLAND PHARMA LIMITED leads with a 37.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Enoxaparin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Enoxaparin export data snapshot — $209.4M · 223 exporters · 118 countriesTransData Nexus · Indian Customs Data

Top Enoxaparin Exporters from India

223 active exporters · Ranked by export value

View all 223 →

Top Enoxaparin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	GLAND PHARMA LIMITED	$79.0M	495	25	37.7%
2	GLAND PHARMA LTD

Top Countries Importing Enoxaparin from India

118 destination markets · Ranked by import value

All 118 countries →

Top Countries Importing Enoxaparin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$102.7M	49.0%
2	SAUDI ARABIA	$46.1M	22.0%
3	SRI LANKA	$7.9M	3.8%
4	CANADA	$5.2M	2.5%
5	DOMINICAN REPUBLIC	$3.4M	1.6%
6	PERU	$3.3M	1.6%
7	BRAZIL	$3.0M	1.4%
8	THAILAND	$2.9M	1.4%
9	MEXICO	$2.9M	1.4%
10	UZBEKISTAN	$2.9M	1.4%

UNITED STATES is India's largest enoxaparin export destination, absorbing 49.0% of total exports worth $102.7M. The top 5 importing countries — UNITED STATES, SAUDI ARABIA, SRI LANKA, CANADA, DOMINICAN REPUBLIC — together account for 78.9% of India's total enoxaparin export value. The remaining 113 destination countries collectively receive the other 21.1%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Enoxaparin to India?

11 origin countries · Total import value: $2.7B

India imports enoxaparin from 11 countries with a combined import value of $2.7B. The largest supplier is FRANCE ($2.7B, 70 shipments), followed by CHINA and ITALY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Enoxaparin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	FRANCE	$2.7B	70	99.8%
2	CHINA	$3.2M	22	0.1%
3	ITALY	$1.4M	4	0.1%
4	SINGAPORE	$1.2M	6	0.0%
5	BRAZIL	$35.4K	12	0.0%
6	UNITED STATES	$11.7K	21	0.0%
7	GERMANY	$10.1K	8	0.0%
8	LATVIA	$4.2K	1	0.0%
9	AUSTRALIA	$509	1	0.0%
10	CANADA	$482	7	0.0%

Showing top 10 of 11 origin countries

FRANCE is the largest supplier of enoxaparin to India, accounting for 99.8% of total import value. The top 5 origin countries — FRANCE, CHINA, ITALY, SINGAPORE, BRAZIL — together supply 100.0% of India's enoxaparin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Enoxaparin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, enoxaparin is regulated by the Food and Drug Administration (FDA) and is available as both branded and generic formulations. The approval of generic enoxaparin under the Abbreviated New Drug Application (ANDA) pathway necessitates demonstrating equivalence to the reference product in terms of physicochemical properties, heparin source material, disaccharide composition, biological activity, and in vivo pharmacodynamic profile. This rigorous framework ensures the safety and efficacy of generic enoxaparin products.

Given that the United States is the leading importer of Indian enoxaparin exports, accounting for 49.0% of the total export value, Indian manufacturers must adhere to FDA regulations to access this market. The presence of 223 active Indian exporters underscores the competitive landscape and the importance of maintaining compliance with FDA standards to ensure market entry and sustainability.

2EU & UK Regulatory Framework

In the European Union (EU), enoxaparin is subject to the European Medicines Agency's (EMA) regulatory oversight. Products like Inhixa, a biosimilar enoxaparin, have received marketing authorization, indicating compliance with EU standards. However, the marketing authorization for Thorinane, another enoxaparin product, lapsed on 15 September 2019 due to the product not being marketed within three years of authorization, as per the EU's "sunset clause." (ema.europa.eu)

The United Kingdom, post-Brexit, has established its own regulatory framework through the Medicines and Healthcare products Regulatory Agency (MHRA). For instance, in June 2025, the MHRA issued a Class 2 medicines recall for Inhixa 12,000 IU (120 mg)/0.8 mL solution for injection due to a typographical error on the packaging. (gov.uk)

3WHO Essential Medicines & Global Standards

Enoxaparin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its critical role in healthcare systems worldwide. The WHO Prequalification Programme ensures that medicines like enoxaparin meet global standards of quality, safety, and efficacy, facilitating their procurement by international agencies.

Pharmacopoeial standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP) provide detailed monographs for enoxaparin, ensuring consistency and quality across different markets.

4India Regulatory Classification

In India, enoxaparin is classified under Schedule H of the Drugs and Cosmetics Rules, 1945, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including enoxaparin, to ensure affordability. Manufacturers intending to export enoxaparin must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with export regulations.

5Patent & Exclusivity Status

The primary patents for enoxaparin have expired, leading to increased generic competition globally. This has resulted in a more competitive market landscape, with multiple manufacturers producing generic versions of enoxaparin, thereby enhancing accessibility and affordability.

6Recent Industry Developments

In June 2025, the MHRA issued a Class 2 medicines recall for Inhixa 12,000 IU (120 mg)/0.8 mL solution for injection due to a typographical error on the packaging, highlighting the importance of accurate labeling in pharmaceutical products. (gov.uk)

In March 2026, the EMA updated the European Public Assessment Report (EPAR) for Inhixa, reflecting ongoing regulatory oversight and the importance of maintaining up-to-date product information. (ema.europa.eu)

These developments underscore the dynamic nature of the regulatory environment for enoxaparin and the necessity for manufacturers to stay informed and compliant with evolving standards to ensure market access and patient safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Enoxaparin

Retail & reference prices across 4 markets vs. India FOB export price of $105.76/unit

Global Price Benchmark for Enoxaparin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$154,000/kg	USD	Pricing influenced by demand from the pharmaceutical sector and regulatory constraints.
Germany	$106,000/kg	USD	Pricing reflects premium quality standards and strict EU manufacturing regulations.
Brazil	$141,000/kg	USD	Pricing driven by limited local manufacturing and high import dependency.
IndiaORIGIN	$26,050/kg

Supply Chain Risk Assessment — Enoxaparin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

The production of Enoxaparin relies heavily on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). India's pharmaceutical industry is notably dependent on China for these critical components. According to a report by the U.S.-China Economic and Security Review Commission published in November 2025, India's production of dexamethasone, used to treat inflammatory and autoimmune conditions, relies on key chemicals such as diosgenin, which is no longer available in India and has to be imported, presumably from China. This dependency exposes the Enoxaparin supply chain to potential disruptions stemming from geopolitical tensions, trade disputes, or regulatory changes in China.

Recent disruptions have underscored this vulnerability. In June 2021, manufacturing issues led to a disruption in the supply of Enoxaparin (Clexane®) 20 mg and 40 mg syringes, as reported by the New South Wales Health Department. Such incidents highlight the fragility of the supply chain and the need for diversification in sourcing strategies.

2Supplier Concentration & Single-Source Risk

The Enoxaparin export market from India is highly concentrated, with the top five exporters accounting for 86.8% of total exports. GLAND PHARMA LIMITED alone contributes $79.0 million USD, representing a 37.7% share. This high level of supplier concentration poses a significant risk; any operational, financial, or compliance issues within these key suppliers could lead to substantial supply disruptions.

Access Complete Enoxaparin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,309 transactions across 118 markets.

Request Demo View Pricing

Frequently Asked Questions — Enoxaparin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top enoxaparin exporters from India?

The leading enoxaparin exporters from India are GLAND PHARMA LIMITED, GLAND PHARMA LTD, BIOLOGICAL E. LIMITED, and 11 others. GLAND PHARMA LIMITED leads with 37.7% market share ($79.0M). The top 5 suppliers together control 86.8% of total export value.

What is the total export value of enoxaparin from India?

The total export value of enoxaparin from India is $209.4M, recorded across 3,309 shipments from 223 active exporters to 118 countries. The average shipment value is $63.3K.

Which countries import enoxaparin from India?

India exports enoxaparin to 118 countries. The top importing countries are UNITED STATES (49.0%), SAUDI ARABIA (22.0%), SRI LANKA (3.8%), CANADA (2.5%), DOMINICAN REPUBLIC (1.6%), which together account for 78.9% of total export value.

What is the HS code for enoxaparin exports from India?

The primary HS code for enoxaparin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Enoxaparin

Enoxaparin

Top Enoxaparin Exporters from India

Top Countries Importing Enoxaparin from India

Who Supplies Enoxaparin to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Regulatory Landscape — Enoxaparin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Enoxaparin

Supply Chain Risk Assessment — Enoxaparin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Enoxaparin Trade Intelligence

Frequently Asked Questions — Enoxaparin Exports from India

Who are the top enoxaparin exporters from India?

What is the total export value of enoxaparin from India?

Which countries import enoxaparin from India?

What is the HS code for enoxaparin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of enoxaparin exports from India?

Which ports handle enoxaparin exports from India?

Why is India a leading exporter of enoxaparin?

What certifications do Indian enoxaparin exporters need?

How many buyers import enoxaparin from India?

What is the market share of the top enoxaparin exporter from India?

Analysis Methodology